Aleksandra Havelka
Fortuna: 12 180 $ al 31/08/2026
Fortuna: 12 180 $ al 31/08/2026
Aleksandra Havelka is currently Chief Scientific Officer at Gentian Diagnostics ASA since 2023.
Formerly, worked as Unit Manager at Karolinska University Hospital.
Completed a doctorate degree at Karolinska Institutet.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENTIAN DIAGNOSTICS ASA 0,02 % | 12/03/2026 | 2.920 ( 0,02 % ) | 12 180 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENTIAN DIAGNOSTICS | Director Técnico/Científico/I+D | - |
| Empresas | Cargo | Fin |
|---|---|---|
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Gentian Diagnostics ASA
Gentian Diagnostics ASA Medical SpecialtiesHealth Technology Develops and manufactures in-vitro diagnostic products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.